Back pain

Low back pain is a major cause of disability worldwide. Data on the prevalence of low back pain are presented. Information on the pathogenesis of pain is given. The temporal characteristics of pain are presented. Risk factors and triggers for episodes of low back pain are reviewed. The most common c...

Full description

Bibliographic Details
Main Author: N. V. Pizova
Format: Article
Language:Russian
Published: Remedium Group LLC 2021-01-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/5967
_version_ 1827961800671363072
author N. V. Pizova
author_facet N. V. Pizova
author_sort N. V. Pizova
collection DOAJ
description Low back pain is a major cause of disability worldwide. Data on the prevalence of low back pain are presented. Information on the pathogenesis of pain is given. The temporal characteristics of pain are presented. Risk factors and triggers for episodes of low back pain are reviewed. The most common causes of specific and non-specific low back pain are described. Non-specific low back pain is more common, as no specific pathological-anatomical cause can be identified. Specific pain includes nociceptive and neuropathic pain. In order to make a correct diagnosis in a patient with low back pain, a thorough medical history must be taken, which usually provides important information in identifying the cause of the pain syndrome. The warning signs (‘red flags’) for specific causes of low back pain requiring urgent treatment and specific psychosocial factors contributing to chronic pain (‘yellow flags’) are considered separately. ‘Red flags’ include conditions such as suspected traumatic injury, tumour, infection or radiculopathy and cauda equina syndrome. «Yellow flags» include individual cognitive, emotional and behavioural factors that contribute to the development of chronic pain. The main aim of pharmacotherapy for low back pain is to enable patients to continue or resume their normal daily activities. The main recommended approaches in the treatment of acute and chronic low back pain are presented. The main non-steroidal anti-inflammatory drugs for the oral drug treatment of non-specific low back pain are described, with evidence-based doses. Special attention is given to the role of diclofenac in the treatment of pain. The authors present the results of systematic reviews that analyse the available data on the efficacy and safety of topical transdermal dosage forms that contain NSAIDs.
first_indexed 2024-04-09T16:32:14Z
format Article
id doaj.art-c55e4f47f9dc42bd84eb6a7a9112b214
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:32:14Z
publishDate 2021-01-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-c55e4f47f9dc42bd84eb6a7a9112b2142023-04-23T06:57:03ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902021-01-01021707710.21518/2079-701X-2020-21-70-775431Back painN. V. Pizova0Yaroslavl State Medical UniversityLow back pain is a major cause of disability worldwide. Data on the prevalence of low back pain are presented. Information on the pathogenesis of pain is given. The temporal characteristics of pain are presented. Risk factors and triggers for episodes of low back pain are reviewed. The most common causes of specific and non-specific low back pain are described. Non-specific low back pain is more common, as no specific pathological-anatomical cause can be identified. Specific pain includes nociceptive and neuropathic pain. In order to make a correct diagnosis in a patient with low back pain, a thorough medical history must be taken, which usually provides important information in identifying the cause of the pain syndrome. The warning signs (‘red flags’) for specific causes of low back pain requiring urgent treatment and specific psychosocial factors contributing to chronic pain (‘yellow flags’) are considered separately. ‘Red flags’ include conditions such as suspected traumatic injury, tumour, infection or radiculopathy and cauda equina syndrome. «Yellow flags» include individual cognitive, emotional and behavioural factors that contribute to the development of chronic pain. The main aim of pharmacotherapy for low back pain is to enable patients to continue or resume their normal daily activities. The main recommended approaches in the treatment of acute and chronic low back pain are presented. The main non-steroidal anti-inflammatory drugs for the oral drug treatment of non-specific low back pain are described, with evidence-based doses. Special attention is given to the role of diclofenac in the treatment of pain. The authors present the results of systematic reviews that analyse the available data on the efficacy and safety of topical transdermal dosage forms that contain NSAIDs.https://www.med-sovet.pro/jour/article/view/5967acute and chronic painlow back paindiagnosistreatmentdiclofenac
spellingShingle N. V. Pizova
Back pain
Медицинский совет
acute and chronic pain
low back pain
diagnosis
treatment
diclofenac
title Back pain
title_full Back pain
title_fullStr Back pain
title_full_unstemmed Back pain
title_short Back pain
title_sort back pain
topic acute and chronic pain
low back pain
diagnosis
treatment
diclofenac
url https://www.med-sovet.pro/jour/article/view/5967
work_keys_str_mv AT nvpizova backpain